News
Radar
Home
Research
Products & Services
Online Data Service
Deals in Europe Report
Radar
Advanced Search
Add Company
Add Person
Customized Research
Weekly Newsletter
Online News
Events
Diatos SA
Biopharmaceutical company focused on the development of novel cancer treatments using its core technologies for tumor selective targeting and intracellular drug delivery.
Diatos is a spin-off from the from Institut Pasteur.
• Show past press releases
• Edit this company
CONTACT INFORMATION
Address:
Phone:
Fax:
Web:
Contact:
166, boulevard du Montparnasse
Paris 75014
France
+33 (0)1 5380 9340
+33 (0)1 5380 9389
http://www.diatos.com
John Tchelingerian
+33 (0)1 5380 9381
COMPANY FACTS
Founded:
Feb 1999
Founders:
Institut Pasteur, Sofinnova Partners
CEO:
Dr John Tchelingerian
CTO or technical lead:
Denis Ravel
CFO or finance director:
Christophe Bourrilly
Head of Sales:
James Cowburn
Head of Marketing:
James Cowburn
Stage:
Growth
Category:
Biotechnology & Healthcare
Sector:
Biopharmaceuticals
Employees:
40
Profitability:
Pre-revenue
Funding raised:
Yes
Funding sought:
No
Seeking Partnerships:
Yes
NON-EXECUTIVE BOARD MEMBERS
KEY CUSTOMERS
KEY BUSINESS PARTNERS
KEY COMPETITORS
CAPITAL RAISED
Date
Size
Investors
To view this information you must be signed in and subscribed to the online dataservice,
sign in
here.
To read more about the Online data service
click here
PUBLIC OFFERINGS
Date
Type
Exchange
No public offerings
Copyright © 1999-2010
Test Publishing Limited
. All rights reserved.
Legal Information
.